H1N1 Influenza-A Virus New Caledonia/20/99 Recombinant ( H1N1 New Caledonia )

Catalog # PT_40070

Print

$201.00
DescriptionRecombinant Full-Length H1N1 New Caledonia/20/99 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is approximately 72 kDa.The insect cells infected with A9440.1a recombinant baculovirus
Product Size: 10ug
Quantity

Data sheet

Formulation
The Recombinant H1N1 A/New Caledonia/20/99 solution 10mM Sodium phosphate, pH 7.2, 150mM NaCl.
Purity
Greater than 90.0% as determined by: Analysis by SDS-PAGE, HA1 and HA2 bands are observed using SDS-PAGE under reducing conditions.
Description
Recombinant Full-Length H1N1 New Caledonia/20/99 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is approximately 72 kDa.The insect cells infected with A9440.1a recombinant baculovirus expressing recombi
Protein Background
H1N1 is a subtype specie of Influenza A virus. H1N1 Influenza Virus has mutated into various strains such as the Spanish Flu strain, mild human flu strains, endemic pig strains, and various strains found in birds. The Influenza A Virus is a globular parti
Expression host
Baculovirus Insect Cells.
Reagent Appearance
Sterile Filtered colorless solution.
Stability
H1N1 A/New Caledonia/20/99 Recombinant should be stored at 4°C. Do not freeze!
Storage Conditions
Rabbit.
References
Title: Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionPublication: The Rockefeller University Press, doi: 10.1084/jem.20101352 © 2011 Wrammert et al. Link:http://jem.rupress.or
New